PhaseBio Pharmaceuticals Inc. (PHAS) Slipped -11.92% or -1.56 To Price $11.56 On Wednesday
PhaseBio Pharmaceuticals Inc. (PHAS) slipped -11.92% or -1.56 to $11.56. It is nearly 252455 shares traded, which is 39.1% compare to the average total volume 645731. The market cap of PHAS is $331.07 million. The year to date change is…